SpectronRx
- Company typePrivate
- Founded2004
- HeadquartersIndianapolis, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
SpectronRx firmographics
Firmographics- Name
- SpectronRx
- Legal name
- SpectronRx
- Website
- https://spectronrx.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
SpectronRx industry classification
Industry- Product category
- Radiopharmaceutical Contract Manufacturing
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Radiopharmaceutical CDMO & Manufacturing (GMP Fill-Finish) (HLAIAGAF)
- akta.pro secondary industries
- Radiopharmaceutical Manufacturing & CDMO (Synthesis, GMP, Packaging, QA/QC) (EUAKAIAC), Diagnostic Radiopharmaceuticals (SPECT/PET Tracers) (HLAIAGAA), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)
Keywords
Where SpectronRx is headquartered
LocationHeadquarters
- HQ city
- Indianapolis
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
SpectronRx business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Infrastructure, Supply Chain, Technology or R&D, Operations, Marketing or Sales
Revenue model
- CDMO Contract Manufacturing Services: Fee-for-service contract manufacturing for radiopharmaceutical development, from preclinical through full commercialization. Services include shared or full-service GMP manufacturing, mAb/nanobody/peptide labeling, and analytical services. Revenue is earned through project-based contracts, equipment leasing, and scalable sharing programs.
- Isotope Production and Sales: Production and global distribution of high-purity medical isotopes (Ac-225, Lu-177, Cu-64, I-131, and others) to pharmaceutical clients. SpectronRx produces isotopes in-house and procures from global supplier network for worldwide delivery.
- Master Services Agreements (MSAs): Long-term manufacturing agreements with pharmaceutical clients such as Plus Therapeutics for GMP manufacturing, technology transfer, and clinical supply. These structured MSAs provide recurring revenue from multi-year engagements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Project-based CDMO services — pricing determined by scope, phase, and isotope requirements |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
SpectronRx product offering
Product offeringCore offering
SpectronRx is a radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) providing end-to-end services from early-phase development through commercialization. Core offerings include GMP manufacturing, mAb/nanobody/peptide radiolabeling, global isotope procurement and in-house production (including proprietary Actinium-225), regulatory assistance through FDA approval, theranostics engineering, analytical services, and worldwide cold-chain logistics for short-lived radiopharmaceuticals.
Product overview
SpectronRx is a radiopharmaceutical CDMO (Contract Development and Manufacturing Organization) providing end-to-end solutions for radiopharmaceutical development and manufacturing. The core offering combines CDMO/RDMO services with isotope procurement and production capabilities, supplemented by mAb/nanobody/peptide labeling, regulatory assistance, worldwide logistics, GMP manufacturing, and theranostics engineering. The company operates multiple facilities across Indiana, Connecticut, and Belgium, supporting over 300,000 patient doses annually with expansion plans for over one million square feet of production space.
Differentiator
Problem solved
Functional benefit
Products and services
- CDMO/RDMO Services Contract Development and Manufacturing Organization (CDMO) and Radiopharmaceutical Development and Manufacturing Organization (RDMO) services providing end-to-end solutions for radiopharmaceutical development from early phase through full commercialization, including shared or full-service GMP manufacturing, technology transfer, and scale-up for pharmaceutical and biotech clients.
- Isotope Procurement and Production Global procurement and in-house production of high-purity medical isotopes including Actinium-225, Iodine-123/131, Copper-64/67, Lutetium-177, Indium-111, Zirconium-89, Cerium-134, Radium-226, Lead-212, Gallium-68, Germanium-68, Strontium-82, and Fluorine-18 for diagnostic imaging and radioligand therapies, distributed globally to six continents.
- Regulatory Assistance Regulatory consulting services specializing in regulatory pathway development from Phase 0 through full FDA approval (including IND filing), facilities design, compliance consulting, equipment validation, cleanroom design and validation, and quality systems support for radiopharmaceutical developers.
- Worldwide Logistics Cold chain logistics services for safe, effective, on-time delivery of radiopharmaceuticals at any temperature worldwide, with chain-of-custody telemetry monitoring to support global distribution of short-lived radioactive drugs.
- Theranostics Engineering Specialized engineering services for designing custom shielding, isotope handling automation, and associated equipment for theranostic applications, supported by an in-house engineering team for specialized tooling and equipment design.
- Analytical Services Drug- and molecule-specific analytical services and comprehensive hardware instrumentation analysis for quality control, analytical method validation, manufacturing process validation, and routine clinical supply support.
Quantifiable outcome
- Over 300,000 patient doses supported annually across current facilities
- +3 more outcomes
Companies that use SpectronRx
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
SpectronRx technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
SpectronRx partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and supporting.
- Plus TherapeuticscorePlus Therapeutics entered into a Master Services Agreement with SpectronRx for GMP manufacturing activities as a second manufacturing site to support late-stage clinical supply for REYOBIQ (rhenium Re186 obisbemeda). The partnership enables on-demand Rhenium-186 isotope production and drug manufacturing within the same facility, strengthening Plus Therapeutics' multi-partner supply chain.
- Bicycle TherapeuticscoreBicycle Therapeutics established strategic partnerships including a collaboration with SpectronRx and UKNNL to develop a bespoke 212Pb generator for targeted alpha therapy in cancer treatments. The partnership aims to create an end-to-end supply chain for Bicycle's wholly owned radiopharmaceutical pipeline, extracting and processing radioisotopes from reprocessed uranium.
- UK Nuclear Decommissioning Authority (NDA)coreBicycle Therapeutics entered a 15-year contract with the UK Nuclear Decommissioning Authority for access to reprocessed uranium (up to 400 tonnes) for development of radiopharmaceuticals for cancer treatment. SpectronRx collaborates with UKNNL under this arrangement to extract and process radioisotopes for targeted alpha therapy.
- UK National Nuclear Laboratory (UKNNL)coreUKNNL collaborates with Bicycle Therapeutics and SpectronRx to extract and process radioisotopes from reprocessed uranium for targeted alpha therapy. UKNNL's nuclear expertise combined with SpectronRx's manufacturing capabilities enables development of bespoke radioisotope generators for the Bicycle Radioconjugate pipeline.
- RadiomedixsupportingExisting supply chain partner within Plus Therapeutics' multi-partner supply network for radiopharmaceutical manufacturing and isotope supply. Part of the established partner ecosystem for clinical supply reliability.
- Telix PharmaceuticalssupportingExisting supply chain partner providing Rhenium-186 isotope supply within Plus Therapeutics' multi-partner supply chain ecosystem. Telix supplies isotopes used in SpectronRx's manufacturing activities for REYOBIQ clinical supply.
Scale indicators6 records
Recent moves9 records
Expansion highlights5 records
SpectronRx competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key highlights6 records
Customer concentration
SpectronRx social profiles
Digital presenceSpectronRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
SpectronRx leadership team
Management profileNumber of profiles
Profiles4 records
SpectronRx funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SpectronRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SpectronRx
What does SpectronRx do?
SpectronRx is a radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) providing end-to-end services from early-phase development through commercialization. Core offerings include GMP manufacturing, mAb/nanobody/peptide radiolabeling, global isotope procurement and in-house production (including proprietary Actinium-225), regulatory assistance through FDA approval, theranostics engineering, analytical services, and worldwide cold-chain logistics for short-lived radiopharmaceuticals.
Is SpectronRx a public or private company?
SpectronRx is a private company. It is classified as private equity controlled and is currently operating.
When was SpectronRx founded?
SpectronRx was founded in 2004. It employs 101 to 250 people.
Where is SpectronRx based?
SpectronRx is headquartered in Indianapolis, United States, in the North America region.
How does SpectronRx make money?
Three revenue lines are on record. CDMO Contract Manufacturing Services are the primary driver. The others are isotope Production and Sales and master Services Agreements (MSAs).
Does SpectronRx have an API?
No public API is recorded for SpectronRx.
What industry is SpectronRx in?
SpectronRx's product category is Radiopharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAIAGAF, Radiopharmaceutical CDMO & Manufacturing (GMP Fill-Finish), with a secondary code of EUAKAIAC, Radiopharmaceutical Manufacturing & CDMO (Synthesis, GMP, Packaging, QA/QC). Its NAICS code is 424210 and its SIC code is 5122.